Priority Date: 31.05.12 (EP 20120170199)

BIOMARKERS FOR DETERMINING EFFECTIVE RESPONSE OF TREATMENTS OF HEPATOCELLULAR CARCINOMA (HCC) PATIENTS

  • Application ID: EP13725651
  • Status: EXAMINATION IN PROGRESS

Applicant

Technology company logo small
Technology Company

Attorneys

Employment test 201 - 500 employees
Company dna hgf ltd
operating since 1995
1327.1
Headquarter in Leeds and 20 offices
active in Legal Services and IP Consulting
Technology company logo thumb
no operation time available
3 offices
Technology Company

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Bayer Intellectual Property GmbH is specialized in A61. Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 31.05.2012 - Priority Date (EP 20120170199)
  • 05.12.2013 - Publication A1 (WO2013178581)
  • 08.04.2015 - Publication A1 (EP2854779)